News
Novavax Announces Positive Phase 1 Data for its COVID-19 Vaccine Candidate
Novavax, Inc., a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, announced Phase 1 data from its Phase 1/2 randomized, observer-blinded, placebo-controlled trial of its COVID 19 vaccine with and without Matrix M™ adjuvant in healthy adults...
News
Sharp acquires stake in Berkshire Sterile Manufacturing
Sharp, part of UDG Healthcare plc, a global leader in contract packaging and clinical supply services, has purchased a minority ownership in Berkshire Sterile Manufacturing (BSM).
Sharp has taken a minority 25% ownership in BSM with the support of UDG...
News
DHL Global forwarding supports Kuwait’s fight against Covid-19
DHL’s global network and expertise in handling humanitarian logistics provide uninterrupted supply of essential COVID-19 medical supplies to Kuwait’s frontline health workers
Over the course of two months, DHL Global Forwarding, the leading international provider of air, sea and road...
News
Lupin Launches Favipiravir Drug Covihalt for Treatment of Mild to Moderate COVID-19
Pharma major Lupin Limited (Lupin) announced the launch of its Favipiravir in India under the brand name Covihalt® for the treatment of mild to moderate COVID-19. Favipiravir has received authorization from the Drug Controller General of India (DCGI) for...
Clinical Trials
Members of the COVID R&D Alliance and Quantum Leap Healthcare Collaborative Enroll First Patients in I-SPY COVID Trial
Members of the COVID R&D Alliance AbbVie, Inc., Amgen Inc., and Takeda Pharmaceutical Co. Ltd. announced the first patients enrolled in the I-SPY COVID Trial (Investigation of Serial Studies to Predict Your COVID Therapeutic Response with Biomarker Integration and...
News
Rigenerand commences 3D bioreactor development for cGMP extracellular vesicle exosomes (EV) production
Rigenerand SRL, the biotech company that both develops and manufactures medicinal products for cell therapy applications, primarily for regenerative medicine and oncology, announces it has commenced development of a novel 3D bioreactor and pipeline, specifically designed for the incremental...
News
Kodak announces initiative to create Kodak Pharmaceuticals
Eastman Kodak Company received a $765 million loan from the United States International Development Finance Corporation (DFC) to support the launch of Kodak Pharmaceuticals, a new arm of the company that will produce critical pharmaceutical components, the DFC and...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.